These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19015953)

  • 41. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma.
    Vielh P; Carton M; Padoy E; de Rycke Y; Klijanienko J; El-Naggar AK; Asselain B
    Cancer; 2005 Dec; 105(6):476-82. PubMed ID: 16116603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum soluble fas level as a prognostic factor in patients with gynecological malignancies.
    Konno R; Takano T; Sato S; Yajima A
    Clin Cancer Res; 2000 Sep; 6(9):3576-80. PubMed ID: 10999747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.
    Noguchi M; Taniya T; Ohta N; Koyasaki N; Miyazaki I; Mizukami Y
    Breast Cancer Res Treat; 1991 Sep; 19(1):23-31. PubMed ID: 1661623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer.
    Reimer T; Koczan D; Müller H; Friese K; Thiesen HJ; Gerber B
    Breast Cancer Res; 2002; 4(5):R9. PubMed ID: 12223126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].
    Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
    Meyer JS; Province MA
    Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
    Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
    Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
    Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
    Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.
    Yokoe T; Izuo M; Ishida T; Iino Y; Kawai T
    Jpn J Surg; 1990 Sep; 20(5):491-7. PubMed ID: 2243441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
    Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
    Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Levels and clinic significance of serum soluble Fas and soluble Fas ligand in coal workers' pneumoconiosis].
    Yuan BJ; Liu ZZ; Ding XR; Zou JM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Feb; 24(2):96-8. PubMed ID: 16600114
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.
    Cook DL; Weaver DL
    Am J Clin Pathol; 1995 Jul; 104(1):17-22. PubMed ID: 7611175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.
    Brower ST; Ahmed S; Tartter PI; Bleiweiss I; Amberson JB
    Ann Surg Oncol; 1995 Sep; 2(5):440-4. PubMed ID: 7496840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors.
    Xu Y; Kimura N; Yoshida R; Lin H; Yoshinaga K
    Oncol Rep; 2001; 8(5):1177-82. PubMed ID: 11496338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.